PortViewPortView
SkyAI logo

SkyAI (STSS) Stock Analysis

NASDAQHealthcareMedical - Instruments & Supplies

$1.27-2.31%
1-year price historyRange $0.95 – $13.55
52-week range$1.27
$0.94$18.23

What SkyAI does

Sharps Technology, Inc., a medical device and pharmaceutical packaging company, provides smart-safety syringe products to the healthcare industry. Its product lines focus on providing waste capabilities that incorporate syringe technologies. The company, through a digital asset treasury strategy, focuses on accumulating Solana (SOL), the native digital asset of the Solana blockchain. The company was incorporated in 2017 and is based in Melville, New York.

Key metrics

Market cap
$53.75M
P/E (TTM)
-0.02
EPS (TTM)
$-64.49
Beta
2.10
Dividend yield
0.00%
Revenue / share
$0.03
50-day avg
$1.77
200-day avg
$3.41
52-week high
$18.23
52-week low
$0.94
CEO
Paul K. Danner

ETFs linked to STSS

Broad-market and Healthcare sector ETFs an investor holding SkyAI is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how STSS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze STSS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for SkyAI?
SkyAI trades under the ticker STSS on NASDAQ.
Which exchange is STSS listed on?
STSS is listed on NASDAQ.
What sector does SkyAI operate in?
SkyAI is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze STSS in a portfolio?
PortView shows STSS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.